Decision Resources DRugwatch Blog Quick insight on intriguing drug market developments from Decision Resources’ analysts. <![CDATA[In anticipation of ASCO]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/qXC1T0y116c" height="1" width="1"/> Tue, 29 May 2012 10:35:37 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/qXC1T0y116c/In-anticipation-of-ASCO-052912 http://decisionresources.com/The-Decision-Resources-Blog/May-2012/In-anticipation-of-ASCO-052912 <![CDATA[NYC Act 2: Market Access, Dinner and a Show ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/uj9Jp8Kp_3c" height="1" width="1"/> Thu, 10 May 2012 13:40:57 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/uj9Jp8Kp_3c/Dinner-and-a-Show-Act-2-051012 http://decisionresources.com/The-Decision-Resources-Blog/May-2012/Dinner-and-a-Show-Act-2-051012 <![CDATA[With the Healthcare Reform Debate Looming, the Supreme Court Strikes Against Personalized Medicine Patent Claims – Connection or Coincidence? ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/xMXNqyn_7iw" height="1" width="1"/> Thu, 29 Mar 2012 14:48:46 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/xMXNqyn_7iw/Supreme-Court-vs-Personalized-Medicine-032912 http://decisionresources.com/The-Decision-Resources-Blog/March-2012/Supreme-Court-vs-Personalized-Medicine-032912 <![CDATA[Payers Will Have the Final Say over PreP]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/t0vR7rWQZlg" height="1" width="1"/> Wed, 14 Mar 2012 12:21:49 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/t0vR7rWQZlg/Payers-and-PreP-031412 http://decisionresources.com/The-Decision-Resources-Blog/March-2012/Payers-and-PreP-031412 <![CDATA[Lexapro: The End of an Era]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/PiQcd5NpvFo" height="1" width="1"/> Thu, 01 Mar 2012 14:44:50 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/PiQcd5NpvFo/Lexapro-030112 http://decisionresources.com/The-Decision-Resources-Blog/March-2012/Lexapro-030112 <![CDATA[Napa Valley Uncorked: How to Sample Napa’s Wine Industry in Only a Day]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/FvF7VOXmJxc" height="1" width="1"/> Thu, 01 Mar 2012 09:50:55 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/FvF7VOXmJxc/Napa-Valley-Uncorked-030112 http://decisionresources.com/The-Decision-Resources-Blog/March-2012/Napa-Valley-Uncorked-030112 <![CDATA[FDA Advisory Committee Get Behind Qnexa]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/8aDQwc_rej0" height="1" width="1"/> Thu, 23 Feb 2012 10:16:55 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/8aDQwc_rej0/FDA-Gets-Behind-Qnexa-022312 http://decisionresources.com/The-Decision-Resources-Blog/February-2012/FDA-Gets-Behind-Qnexa-022312 <![CDATA[Finally! The FDA Issues Draft Guidance for Biosimilars]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/6rguF4z5-B8" height="1" width="1"/> Tue, 14 Feb 2012 10:06:54 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/6rguF4z5-B8/FDA-Guidelines-for-Biosimilars-021412 http://decisionresources.com/The-Decision-Resources-Blog/February-2012/FDA-Guidelines-for-Biosimilars-021412 <![CDATA[Good News for Bydureon, but Bad News for Dapagliflozin]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/ei7kvz0iWRU" height="1" width="1"/> Tue, 07 Feb 2012 12:51:17 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/ei7kvz0iWRU/Mixed-News-for-Type-2-Diabetes-Market-020812 http://decisionresources.com/The-Decision-Resources-Blog/February-2012/Mixed-News-for-Type-2-Diabetes-Market-020812 <![CDATA[MDV3100 - Another Novel Agent Extends the Menu of Treatment Options for Prostate Cancer]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/3rNENB0HsN0" height="1" width="1"/> Tue, 07 Feb 2012 08:44:31 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/3rNENB0HsN0/MDV3100-Prostate-Cancer-020712 http://decisionresources.com/The-Decision-Resources-Blog/February-2012/MDV3100-Prostate-Cancer-020712 <![CDATA[A New Era and Market Opportunity for Multaq ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/Fjp0usft1xw" height="1" width="1"/> Fri, 20 Jan 2012 09:12:09 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/Fjp0usft1xw/New-Era-for-Multaq-012012 http://decisionresources.com/The-Decision-Resources-Blog/January-2012/New-Era-for-Multaq-012012 <![CDATA[Paula Deen and Questioning Celebrity Drug Endorsements]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/L3Aoz9TQTBk" height="1" width="1"/> Thu, 19 Jan 2012 13:15:13 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/L3Aoz9TQTBk/Paula-Deen-Celeb-Endorsements-011912 http://decisionresources.com/The-Decision-Resources-Blog/January-2012/Paula-Deen-Celeb-Endorsements-011912 <![CDATA[The current shortage of Doxil across the major markets]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/xoNbS2RBTtM" height="1" width="1"/> Tue, 17 Jan 2012 11:47:06 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/xoNbS2RBTtM/Doxil-Shortage-011712 http://decisionresources.com/The-Decision-Resources-Blog/January-2012/Doxil-Shortage-011712 <![CDATA[Diabetes Drug Development: 2011 Year in Review and a Look Ahead Towards 2012 And Beyond – Part 2]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/kNf_t2GOiH4" height="1" width="1"/> Mon, 09 Jan 2012 15:04:20 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/kNf_t2GOiH4/Diabetes-2011-Year-In-Review-P2-010912 http://decisionresources.com/The-Decision-Resources-Blog/January-2012/Diabetes-2011-Year-In-Review-P2-010912 <![CDATA[Diabetes Drug Development: 2011 Year in Review and a Look Ahead Towards 2012 And Beyond – Part 1]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/DkyOLuVGY90" height="1" width="1"/> Fri, 06 Jan 2012 12:25:06 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/DkyOLuVGY90/Diabetes-2011-Year-In-Review-P1-010612 http://decisionresources.com/The-Decision-Resources-Blog/January-2012/Diabetes-2011-Year-In-Review-P1-010612 <![CDATA[A Not So Merry Xmas for Vivus’s Qnexa...]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/OLnFm1DXUqc" height="1" width="1"/> Mon, 26 Dec 2011 14:28:49 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/OLnFm1DXUqc/Vivus-Qnexa-122611 http://decisionresources.com/The-Decision-Resources-Blog/December-2011/Vivus-Qnexa-122611 <![CDATA[Following in the Footsteps of Multaq: Can Emerging Antiarrhythmic Drugs Address Key Unmet Needs in Atrial Fibrillation?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/cgHhh5Wmqog" height="1" width="1"/> Mon, 12 Dec 2011 09:56:06 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/cgHhh5Wmqog/Atrial-Fibrillation-121211 http://decisionresources.com/The-Decision-Resources-Blog/December-2011/Atrial-Fibrillation-121211 <![CDATA[The FDA finally draws the line on Avastin in breast cancer ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/ll5aNv1LY60" height="1" width="1"/> Mon, 28 Nov 2011 09:15:38 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/ll5aNv1LY60/Avastin-breast-cancer-112811 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Avastin-breast-cancer-112811 <![CDATA[Emerging Agents Poised to Address the Unmet Need in Third-Line Metastatic Colorectal Cancer]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/3r6v8gwGrGc" height="1" width="1"/> Tue, 22 Nov 2011 09:29:26 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/3r6v8gwGrGc/Metastatic-Colorectal-Cancer-112211 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Metastatic-Colorectal-Cancer-112211 <![CDATA[The End of the Road for Amylin and Lilly’s Diabetes Pact]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/jsiPwY1a7ho" height="1" width="1"/> Thu, 17 Nov 2011 10:51:09 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/jsiPwY1a7ho/Amylin-Lilly-Deal-111711 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Amylin-Lilly-Deal-111711 <![CDATA[A Rose by Any Other Name is Still a New Market Access Strategy]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/yn3Pf62Zn5M" height="1" width="1"/> Mon, 14 Nov 2011 10:54:33 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/yn3Pf62Zn5M/New-Market-Access-Strategy-111411 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/New-Market-Access-Strategy-111411 <![CDATA[Pfizer’s Q3 results surprise on the upside – but Lipitor patent loss looms]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/r9f81fAl9Us" height="1" width="1"/> Thu, 10 Nov 2011 10:07:29 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/r9f81fAl9Us/Pfizer-Q3-results-111011 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Pfizer-Q3-results-111011 <![CDATA[Is Contagion contagious enough to become a blockbuster?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/SX5AGf793bQ" height="1" width="1"/> Mon, 07 Nov 2011 08:55:12 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/SX5AGf793bQ/Contagion-Review-110711 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Contagion-Review-110711 <![CDATA[Stronger Third Quarter Earnings for Merck -on Vaccine Recovery and Cost Cuts]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/OYmXY9ctchI" height="1" width="1"/> Tue, 01 Nov 2011 09:49:12 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/OYmXY9ctchI/Merck-Q3-results-110111 http://decisionresources.com/The-Decision-Resources-Blog/November-2011/Merck-Q3-results-110111 <![CDATA[BMS’ Results Show Continued Top-line Momentum and New Product Progress]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/Pfq-vnesEvo" height="1" width="1"/> Fri, 28 Oct 2011 15:00:15 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/Pfq-vnesEvo/Bristol-Myers-Squibb-Q3-results-102811 http://decisionresources.com/The-Decision-Resources-Blog/October-2011/Bristol-Myers-Squibb-Q3-results-102811